Meek David D.

Director at QURE; Chief Executive Officer at Mirati Therapeutics, Inc.; Chief Commercial Officer at ENDOCYTE INC

Sold, on record
$697k
Dollars the filings state
Form 4 sales
11
Latest Jun 11, 2026
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale QUREPlan not stated
    Feb 28, 2022 2022

    Sold 602 shares at $16.70 ($10k)

    Meek David D., Director

    Sold 7.5% of holdings ($133k position)7,380 shares leftFiling

  2. 2 Form 4 sale Mirati Therapeutics, Inc.Plan not stated
    Dec 21, 2022 +296 days

    Sold 4,616 shares at $40.41 ($187k)

    Meek David D., Chief Executive Officer

    Sold 6.6% of holdings ($2.8M position)64,971 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale Mirati Therapeutics, Inc.Plan not stated
    Jan 17, 2023 +27 days

    Sold 3,179 shares at $42.38 ($135k)

    Meek David D., Chief Executive Officer

    Sold 4.9% of holdings ($2.8M position)61,792 shares leftFiling

  4. 4 Form 4 sale QUREPlan not stated
    Feb 27, 2023 +41 days

    Sold 389 shares at $19.71 ($8k)

    Meek David D., Director

    Sold 2.4% of holdings ($324k position)16,071 shares leftFiling

  5. 5 Form 4 sale QURENo plan
    Jun 16, 2023 +109 days

    Sold 2,290 shares at $18.85 ($43k)

    Meek David D., Director

    No 10b5-1 planSold 9.2% of holdings ($467k position)22,481 shares leftFiling

  6. 6 Form 4 sale QURENo plan
    Jun 13, 2024 +363 days

    Sold 2,229 shares at $5.12 ($11k)

    Meek David D., Director

    No 10b5-1 planSold 9.9% of holdings ($115k position)20,252 shares leftFiling

  7. 7 Form 4 sale QURENo plan
    Jun 20, 2025 +372 days

    Sold 2,112 shares at $14.45 ($31k)

    Meek David D., Director

    No 10b5-1 planSold 5.8% of holdings ($525k position)34,190 shares leftFiling

  8. 8 Form 4 sale QURENo plan
    Jun 11, 2026 +356 days

    Sold 1,993 shares at $27.06 ($54k)

    Meek David D., Director

    No 10b5-1 planSold 4.8% of holdings ($1.1M position)39,747 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (11)

Form 144 notices and Form 4 sales by Meek David D.
Source
Jun 11, 2026Jun 12, 2026QUREDirectorForm 4 sale1,993$54k4.8%No planSEC
Jun 20, 2025Jun 24, 2025QUREDirectorForm 4 sale2,112$31k5.8%No planSEC
Jun 13, 2024Jun 17, 2024QUREDirectorForm 4 sale2,229$11k9.9%No planSEC
Jun 16, 2023Jun 20, 2023QUREDirectorForm 4 sale2,290$43k9.2%No planSEC
Feb 27, 2023Mar 1, 2023QUREDirectorForm 4 sale389$8k2.4%Plan not statedSEC
Jan 17, 2023Jan 19, 2023Mirati Therapeutics, Inc.Chief Executive OfficerForm 4 sale3,179$135k4.9%Plan not statedSEC
Dec 21, 2022Dec 21, 2022Mirati Therapeutics, Inc.Chief Executive OfficerForm 4 sale4,616$187k6.6%Plan not statedSEC
Feb 28, 2022Mar 2, 2022QUREDirectorForm 4 sale602$10k7.5%Plan not statedSEC
Mar 2, 2021Mar 4, 2021QUREDirectorForm 4 sale505$19k7.3%Plan not statedSEC
Jan 28, 2020Jan 30, 2020QUREDirectorForm 4 sale722$45k22.4%Plan not statedSEC
Sep 12, 2013Sep 16, 2013ENDOCYTE INCChief Commercial OfficerForm 4 sale10,000$155k100.0%UnusualSEC